entity

Jason Bock

Facts (5)

Sources
New cell therapy model accelerates cancer treatment development drugtargetreview.com Drug Target Review Feb 10, 2025 5 facts
claimJason Bock earned a BSc in Biology from the Massachusetts Institute of Technology and a PhD in Molecular and Cellular Physiology from the Stanford University School of Medicine.
claimJason Bock, the co-founder and CEO of CTMC, advocates for a model of patient-adjacent manufacturing where industrial cell therapy manufacturing facilities are integrated with large medical centers.
claimJason Bock believes that integrating cell therapy manufacturing with large medical centers like MD Anderson can be replicated globally to increase patient access to cell therapies.
claimJason Bock previously held leadership roles at MD Anderson, Teva Pharmaceuticals, CoGenesys, and Human Genome Sciences.
claimJason Bock, PhD, is the co-founder and CEO of CTMC and has over 20 years of experience in innovative biologics development and commercialisation.